Some Ozempic customers are administering customized doses, injecting completely different quantities of the drug than these particularly indicated by the producer’s directions. They do it by “counting clicks” — hacking the supply system to attract up ostensibly exact doses that fall...
The first nasally administered glucagon product has been permitted by the US Food and Drug Administration (FDA) to treat severe hypoglycemia. Baqsimi is first nasal glucagon product to receive US approval to treat severe hypoglycemia happens when blood glucose ranges fall...
The U.S. Food and Drug Administration (FDA) lately granted expanded approval to Eversense, a steady glucose monitoring system that features a tiny implantable sensor and wearable transmitter to observe glucose for 90 days. Available since September 2018, Eversense is newly accredited...
US researchers need to test whether or not a standard tuberculosis vaccine could assist prevent type 1 diabetes in children. A group from the Massachusetts General Hospital say they’ve proof to recommend that the Bacillus Calmette-Guerin (BCG) vaccine has been efficient...
The diabetes drug Suliqua has been accepted to be used in a wider vary of individuals within the US. The US Food and Drugs Administration expanded its indication for the drug on Wednesday 27 February. Suliqua, developed by Sanofi, is a...
The first mobile app that determines insulin doses for individuals with kind 2 diabetes has been formally accepted within the US. The app, designed to work alongside the d-Nav Insulin Guidance Service, has been given the seal of approval by the...
Drivers with diabetes who use insulin will quickly have the ability to use the FreeStyle Libre and steady glucose monitoring (CGM), in accordance with the Diabetes Times. The DVLAs Medical Advisory Panel had in June accredited use of the expertise, however...
Pops! Diabetes Care has introduced that its Pops! one Blood Glucose Monitoring System has acquired approval from the U.S. Food and Drug Administration (FDA), clearing the best way for the product to be out there for buy in early 2019. As...
The pioneering synthetic pancreas developed for individuals with kind 1 diabetes has been hailed as “brilliant” by Camilla, the Duchess of Cornwall. The modern expertise was the point of interest of her royal go to to Addenbrooke’s Hospital in Cambridge, the...
People with diabetes might be one step nearer to having ‘do it your self’ technology permitted by regulators, it has been introduced. Tidepool, a not-for-profit organisation, is working with the US Food and Drug Administration (FDA) in a bid to discover...